Literature DB >> 11113353

Synaptic localization of ionotropic glutamate receptors in the rat substantia nigra.

B T Chatha1, V Bernard, P Streit, J P Bolam.   

Abstract

Glutamatergic neurotransmission in the substantia nigra pars compacta and pars reticulata is mediated through N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxaline propionic acid/kainate (AMPA) type receptors as well as other glutamate receptors and is critical for basal ganglia functioning. A major glutamatergic input to the substantia nigra originates in the subthalamic nucleus, and the long-lasting stimulation of the dopaminergic cells of the substantia nigra pars compacta by the subthalamic neurons has been implicated in the pathophysiology of Parkinson's disease. The objectives of the present study were to determine the subcellular and subsynaptic localization of subunits of the N-methyl-D-aspartate and AMPA receptors in the substantia nigra, and also to determine whether co-localization of N-methyl-D-aspartate and AMPA receptor subunits occur at individual synapses. To achieve this, pre-embedding and post-embedding immunocytochemistry was applied to sections of substantia nigra using antibodies that recognize the NR1 and NR2A/B subunits of the N-methyl-D-aspartate receptor, and GluR2/3 subunits of the AMPA receptor. In both regions of the substantia nigra, immunolabelling for each of the subunits was observed in numerous perikarya and proximal dendrites. At the subcellular level, silver-intensified immunogold particles localizing N-methyl-D-aspartate and AMPA receptor subunits were most commonly present within dendrites where they were associated with a variety of intracellular organelles and with the internal surface of the plasma membrane. Post-embedding immunogold labelling revealed immunoparticles labelling for NR1, NR2A/B and GluR2/3 to be enriched at asymmetric synaptic specializations, although a large proportion of asymmetric synapses were immunonegative. Double immunolabelling revealed, in addition to single-labelled synapses, the co-localization of subunits of the N-methyl-D-aspartate receptor and subunits of the AMPA receptor at individual asymmetric synapses. Similarly, double immunolabelling also revealed the co-localization of the NRl and NR2A/B subunits of the N-methyl-D-aspartate receptor at individual asymmetric synapses. Labelling for NR1 and GluR2/3 was, on average, relatively evenly distributed across the width of the synapse with a gradual reduction towards the periphery when analysed in single sections. In summary, the present results demonstrate that AMPA and N-methyl-D-aspartate receptors are selectively localized at a subpopulation of asymmetric synapses in the substantia nigra pars compacta and reticulata and that the two receptor types, at least partially co-localize at individual synapses. It is concluded that glutamatergic transmission in the substantia nigra pars compacta and pars reticulata occurs primarily at asymmetric synapses and, at least in part, is mediated by both N-methyl-D-aspartate and AMPA receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11113353     DOI: 10.1016/s0306-4522(00)00432-2

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  16 in total

Review 1.  Glutamate and GABA receptors and transporters in the basal ganglia: what does their subsynaptic localization reveal about their function?

Authors:  A Galvan; M Kuwajima; Y Smith
Journal:  Neuroscience       Date:  2006-10-23       Impact factor: 3.590

2.  BDNF mediates the neuroprotective effects of positive AMPA receptor modulators against MPP+-induced toxicity in cultured hippocampal and mesencephalic slices.

Authors:  H Jourdi; L Hamo; T Oka; A Seegan; M Baudry
Journal:  Neuropharmacology       Date:  2009-01-21       Impact factor: 5.250

3.  The organization of AMPA receptor subunits at the postsynaptic membrane.

Authors:  Amanda L Jacob; Richard J Weinberg
Journal:  Hippocampus       Date:  2015-01-19       Impact factor: 3.899

4.  Somatic and neuritic spines on tyrosine hydroxylase-immunopositive cells of rat retina.

Authors:  Anna Fasoli; James Dang; Jeffrey S Johnson; Aaron H Gouw; Alex Fogli Iseppe; Andrew T Ishida
Journal:  J Comp Neurol       Date:  2017-02-13       Impact factor: 3.215

5.  A dynamic role for GABA receptors on the firing pattern of midbrain dopaminergic neurons.

Authors:  Collin J Lobb; Charles J Wilson; Carlos A Paladini
Journal:  J Neurophysiol       Date:  2010-05-05       Impact factor: 2.714

6.  Paraquat as an Environmental Risk Factor in Parkinson's Disease Accelerates Age-Related Degeneration Via Rapid Influx of Extracellular Zn2+ into Nigral Dopaminergic Neurons.

Authors:  Haruna Tamano; Ryusuke Nishio; Hiroki Morioka; Ryo Furuhata; Yuuma Komata; Atsushi Takeda
Journal:  Mol Neurobiol       Date:  2019-05-22       Impact factor: 5.590

Review 7.  Therapeutic potential of targeting glutamate receptors in Parkinson's disease.

Authors:  Clare Finlay; Susan Duty
Journal:  J Neural Transm (Vienna)       Date:  2014-02-21       Impact factor: 3.575

8.  Haloperidol treatment after high-dose methamphetamine administration is excitotoxic to GABA cells in the substantia nigra pars reticulata.

Authors:  Theo Hatzipetros; Jamie G Raudensky; Jean-Jacques Soghomonian; Bryan K Yamamoto
Journal:  J Neurosci       Date:  2007-05-30       Impact factor: 6.167

9.  Functional alpha7-containing nicotinic acetylcholine receptors localize to cell bodies and proximal dendrites in the rat substantia nigra pars reticulata.

Authors:  Olga V Poisik; Jian-xin Shen; Susan Jones; Jerrel L Yakel
Journal:  J Physiol       Date:  2008-03-01       Impact factor: 5.182

Review 10.  Targeting glutamate receptors to tackle the pathogenesis, clinical symptoms and levodopa-induced dyskinesia associated with Parkinson's disease.

Authors:  Susan Duty
Journal:  CNS Drugs       Date:  2012-12       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.